相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses
Mingyu He et al.
SCIENCE (2023)
Cytotoxic CD8+T cells in cancer and cancer immunotherapy
Hans Raskov et al.
BRITISH JOURNAL OF CANCER (2021)
Hypoxia Accelerate β-actin Expression through Transcriptional Activation of ACTB by Nuclear Respiratory Factor-1
X. T. Wang et al.
MOLECULAR BIOLOGY (2021)
Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function
Faizah Alotaibi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Pre-existing chromatin accessibility and gene expression differences among naive CD4+ T cells influence effector potential
Dakota Rogers et al.
CELL REPORTS (2021)
Hypoxia in Solid Tumors: How Low Oxygenation Impacts the Six Rs of Radiotherapy
Andria Rakotomalala et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Integrating distal and proximal information to predict gene expression via a densely connected convolutional neural network
Wanwen Zeng et al.
BIOINFORMATICS (2020)
CD5 dynamically calibrates basal NF-xB signaling in T cells during thymic development and peripheral activation
Courtney A. Matson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Anliang Xia et al.
FRONTIERS IN IMMUNOLOGY (2019)
Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer
Nigar Dirican et al.
CLINICAL RESPIRATORY JOURNAL (2017)
Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function
Yael Gropper et al.
CELL REPORTS (2017)
CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes
Sara Labiano et al.
ONCOIMMUNOLOGY (2017)
Hypoxia Enhances Immunosuppression by Inhibiting CD4(+) Effector T Cell Function and Promoting Treg Activity
Astrid M. Westendorf et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Exonal switch down-regulates the expression of CD5 on blasts of acute T cell leukaemia
A. K. Rai et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Hypoxia and antitumor CD8+ T cells: An incompatible alliance?
Romain Vuillefroy de Silly et al.
ONCOIMMUNOLOGY (2016)
CD5 as a Target for Immune-Based Therapies
Marta Consuegra-Fernandez et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
Aberrant Immunophenotypic Expression of CD5 in a Case of B Acute Lymphoblastic Leukemia: A Case Report
Deepti Mutreja et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2014)
Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
Andrew L. Doedens et al.
NATURE IMMUNOLOGY (2013)
T-cell modulatory properties of CD5 and its role in antitumor immune responses
Mouna Tabbekh et al.
ONCOIMMUNOLOGY (2013)
Rescue of Tumor-Infiltrating Lymphocytes from Activation-Induced Cell Death Enhances the Antitumor CTL Response in CD5-Deficient Mice
Mouna Tabbekh et al.
JOURNAL OF IMMUNOLOGY (2011)
Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes
Soizie Garaud et al.
JOURNAL OF IMMUNOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death
Grzegorz Friedlein et al.
JOURNAL OF IMMUNOLOGY (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes
Y Renaudineau et al.
GENES AND IMMUNITY (2005)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes
Y Renaudineau et al.
BLOOD (2005)
In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity
G Dorothée et al.
JOURNAL OF IMMUNOLOGY (2005)
分享论文
